CYTOMX THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

19 نوفمبر 2024 08:56:48 بحسب NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

18 نوفمبر 2024 08:58:03 بحسب NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

15 نوفمبر 2024 08:54:07 بحسب NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

11 نوفمبر 2024 09:14:07 بحسب NetDania Notify

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

07 نوفمبر 2024 15:10:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

06 نوفمبر 2024 13:45:07 بحسب NetDania Notify

CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024

31 أكتوبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

29 أكتوبر 2024 14:57:21 بحسب NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

28 أكتوبر 2024 10:30:57 بحسب NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

25 أكتوبر 2024 10:27:19 بحسب NetDania Notify

CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors

09 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming September Investor Conferences

04 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

08 أغسطس 2024 15:10:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

01 أغسطس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

18 يونيو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

17 يونيو 2024 15:15:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

22 مايو 2024 15:05:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

16 مايو 2024 15:15:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

08 مايو 2024 15:10:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)

08 مايو 2024 15:10:00 بحسب Nasdaq GlobeNewswire